A multi-center, multinational, Phase 3, randomized, double-blind, parallel
group, placebo-controlled trial of the efficacy and safety of rotigotine CDS patch (2 target
doses) in subjects with advanced-stage, idiopathic Parkinson?s disease who are not well
controlled on levodopa
Not available
Parkinson's Disease
Phase 3
Currently not available on Sponsor Clinical Study Registry but will be included in the next stepwise expansion of the Registry's scope (by end of Q1 2015).

Analysis and Reporting Dataset is AD not ADaM

Datasets are available in English only

CRFs are seperate files per year

Study is not posted on ClinTrials Gov because it completed prior to registry reporting requirements
July 2014